Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA/INSERISCI in fondo alla pagina
SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara
The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of approximately 1800 drug targets, and about 6000 interactions with about 3900 ligands. There is an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (), which provides more detailed views of target and ligand properties. Although the Concise Guide constitutes almost 500 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point-in-time record that will survive database updates. The full contents of this section can be found at . G protein-coupled receptors are one of the six major pharmacological targets into which the Guide is divided, with the others being: ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid-2023, and supersedes data presented in the 2021/22, 2019/20, 2017/18, 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC-IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
Alexander, Stephen P H;Christopoulos, Arthur;Davenport, Anthony P;Kelly, Eamonn;Mathie, Alistair A;Peters, John A;Veale, Emma L;Armstrong, Jane F;Faccenda, Elena;Harding, Simon D;Davies, Jamie A;Abbracchio, Maria Pia;Abraham, George;Agoulnik, Alexander;Alexander, Wayne;Al-Hosaini, Khaled;Bäck, Magnus;Baker, Jillian G;Barnes, Nicholas M;Bathgate, Ross;Beaulieu, Jean-Martin;Beck-Sickinger, Annette G;Behrens, Maik;Bernstein, Kenneth E;Bettler, Bernhard;Birdsall, Nigel J M;Blaho, Victoria;Boulay, Francois;Bousquet, Corinne;Bräuner-Osborne, Hans;Burnstock, Geoffrey;Caló, Girolamo;Castaño, Justo P;Catt, Kevin J;Ceruti, Stefania;Chazot, Paul;Chiang, Nan;Chini, Bice;Chun, Jerold;Cianciulli, Antonia;Civelli, Olivier;Clapp, Lucie H;Couture, Réjean;Cox, Helen M;Csaba, Zsolt;Dahlgren, Claes;Dent, Gordon;Douglas, Steven D;Dournaud, Pascal;Eguchi, Satoru;Escher, Emanuel;Filardo, Edward J;Fong, Tung;Fumagalli, Marta;Gainetdinov, Raul R;Garelja, Michael L;de Gasparo, Marc;Gerard, Craig;Gershengorn, Marvin;Gobeil, Fernand;Goodfriend, Theodore L;Goudet, Cyril;Grätz, Lukas;Gregory, Karen J;Gundlach, Andrew L;Hamann, Jörg;Hanson, Julien;Hauger, Richard L;Hay, Debbie L;Heinemann, Akos;Herr, Deron;Hollenberg, Morley D;Holliday, Nicholas D;Horiuchi, Mastgugu;Hoyer, Daniel;Hunyady, László;Husain, Ahsan;IJzerman, Adriaan P;Inagami, Tadashi;Jacobson, Kenneth A;Jensen, Robert T;Jockers, Ralf;Jonnalagadda, Deepa;Karnik, Sadashiva;Kaupmann, Klemens;Kemp, Jacqueline;Kennedy, Charles;Kihara, Yasuyuki;Kitazawa, Takio;Kozielewicz, Pawel;Kreienkamp, Hans-Jürgen;Kukkonen, Jyrki P;Langenhan, Tobias;Larhammar, Dan;Leach, Katie;Lecca, Davide;Lee, John D;Leeman, Susan E;Leprince, Jérôme;Li, Xaria X;Lolait, Stephen J;Lupp, Amelie;Macrae, Robyn;Maguire, Janet;Malfacini, Davide;Mazella, Jean;McArdle, Craig A;Melmed, Shlomo;Michel, Martin C;Miller, Laurence J;Mitolo, Vincenzo;Mouillac, Bernard;Müller, Christa E;Murphy, Philip M;Nahon, Jean-Louis;Ngo, Tony;Norel, Xavier;Nyimanu, Duuamene;O'Carroll, Anne-Marie;Offermanns, Stefan;Panaro, Maria Antonietta;Parmentier, Marc;Pertwee, Roger G;Pin, Jean-Philippe;Prossnitz, Eric R;Quinn, Mark;Ramachandran, Rithwik;Ray, Manisha;Reinscheid, Rainer K;Rondard, Philippe;Rovati, G Enrico;Ruzza, Chiara;Sanger, Gareth J;Schöneberg, Torsten;Schulte, Gunnar;Schulz, Stefan;Segaloff, Deborah L;Serhan, Charles N;Singh, Khuraijam Dhanachandra;Smith, Craig M;Stoddart, Leigh A;Sugimoto, Yukihiko;Summers, Roger;Tan, Valerie P;Thal, David;Thomas, Walter Wally;Timmermans, Pieter B M W M;Tirupula, Kalyan;Toll, Lawrence;Tulipano, Giovanni;Unal, Hamiyet;Unger, Thomas;Valant, Celine;Vanderheyden, Patrick;Vaudry, David;Vaudry, Hubert;Vilardaga, Jean-Pierre;Walker, Christopher S;Wang, Ji Ming;Ward, Donald T;Wester, Hans-Jürgen;Willars, Gary B;Williams, Tom Lloyd;Woodruff, Trent M;Yao, Chengcan;Ye, Richard D
2023
Abstract
The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of approximately 1800 drug targets, and about 6000 interactions with about 3900 ligands. There is an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (), which provides more detailed views of target and ligand properties. Although the Concise Guide constitutes almost 500 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point-in-time record that will survive database updates. The full contents of this section can be found at . G protein-coupled receptors are one of the six major pharmacological targets into which the Guide is divided, with the others being: ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid-2023, and supersedes data presented in the 2021/22, 2019/20, 2017/18, 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC-IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.
Alexander, Stephen P H; Christopoulos, Arthur; Davenport, Anthony P; Kelly, Eamonn; Mathie, Alistair A; Peters, John A; Veale, Emma L; Armstrong, Jane...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2550950
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
Citazioni
ND
127
124
social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
Il report seguente simula gli indicatori relativi alla propria produzione scientifica in relazione alle soglie ASN 2023-2025 del proprio SC/SSD. Si ricorda che il superamento dei valori soglia (almeno 2 su 3) è requisito necessario ma non sufficiente al conseguimento dell'abilitazione. La simulazione si basa sui dati IRIS e sugli indicatori bibliometrici alla data indicata e non tiene conto di eventuali periodi di congedo obbligatorio, che in sede di domanda ASN danno diritto a incrementi percentuali dei valori. La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. Si consideri che Anvur calcola i valori degli indicatori all'ultima data utile per la presentazione delle domande.
La presente simulazione è stata realizzata sulla base delle specifiche raccolte sul tavolo ER del Focus Group IRIS coordinato dall’Università di Modena e Reggio Emilia e delle regole riportate nel DM 589/2018 e allegata Tabella A. Cineca, l’Università di Modena e Reggio Emilia e il Focus Group IRIS non si assumono alcuna responsabilità in merito all’uso che il diretto interessato o terzi faranno della simulazione. Si specifica inoltre che la simulazione contiene calcoli effettuati con dati e algoritmi di pubblico dominio e deve quindi essere considerata come un mero ausilio al calcolo svolgibile manualmente o con strumenti equivalenti.